Back to Search Start Over

Ireland : Allergan Announces Positive Phase 3 Achieve Ii Trial Results For Ubrogepant Published In The Journal Of The American Medical Association

Source :
Mena Report. November 25, 2019
Publication Year :
2019

Abstract

Allergan plc announced that positive results from ACHIEVE II (UBR-MD-02), a pivotal Phase 3 clinical trial evaluating the efficacy, safety and tolerability of ubrogepant, have been published in the November [...]

Details

Language :
English
ISSN :
22190112
Database :
Gale General OneFile
Journal :
Mena Report
Publication Type :
News
Accession number :
edsgcl.606720697